Realbotix says Nasdaq reverse takeover listing for unit expected to close by October 2026

• Realbotix provided an update on its plan to list its wholly owned unit Realbotix LLC on the Nasdaq Capital Market via a reverse takeover with Onconetix.
• The deal would shift the commercial robotics and AI business into a Nasdaq-listed entity, with Realbotix expected to retain a 75-90% ownership stake.
• The transaction remains subject to Onconetix shareholder and regulatory clearances, with closing targeted by October 2026.
• Realbotix said no action is required from its shareholders, citing no change to the parent-company structure, no parent-level share issuance, and no share consolidation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Realbotix Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260519598336) on May 19, 2026, and is solely responsible for the information contained therein.